Eli Lilly Partners with State of Indiana to Accelerate COVID-19 Testing
Jonathan Weiss / Shutterstock
As the number of diagnosed cases of COVID-19 continues to rise in the United States, Eli Lilly has partnered with the
Indiana has not yet been as hard hit by diagnoses of SARS-CoV-2, the virus that causes COVID-19, but that’s not stopping the state from pairing up with its hometown pharma giant. According to the Indianapolis Star, there have been 56 diagnosed cases of the virus in Indiana as of Thursday, a spike of 17 new cases from the previous day.
David A. Ricks, chairman and chief executive officer of Indianapolis-based Eli Lilly, said the company was “bringing the full force of its scientific and medical expertise” to address COVID-19, which was declared a pandemic by the World Health Organization last week.
“For more than 140 years
Lilly will use its specialized research laboratories to analyze samples taken in
Lilly will not accept money from government agencies, hospitals, insurance companies or patients for conducting or analyzing tests. Ricks said the work it is doing with the state is a contribution Eli Lilly can make to help slow the spread of coronavirus in its home community. And, this testing will be entirely free, Ricks added.
Indiana State Health Commissioner Kris Box, said Eli Lilly’s capabilities will have a significant impact on how the people of Indiana, as well as those worldwide.
“As the global COVID-19 pandemic has intensified,